# Ovid Therapeutics Inc.: Form 8-K, filed Jun 25, 2025

- Company: [Ovid Therapeutics Inc.](/companies/ovid.md) (CIK 1636651)
- Form: 8-K
- Filed: 2025-06-25
- Accepted by EDGAR: Jun 25, 2025, 08:22 ET
- Period: 2025-06-25
- Accession: 0001628280-25-032959
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1636651/000162828025032959/ovid-20250625.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1636651/000162828025032959/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1636651/000162828025032959/ovid-20250625.htm

Filed Jun 25, 2025.
Source: SEC EDGAR, the filing index for accession 0001628280-25-032959. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.